Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
479 studies found for:    Open Studies | "Glioma"
Show Display Options
Rank Status Study
21 Recruiting A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Condition: Malignant Glioma
Intervention: Drug: Fluorine-18-L-dihydroxyphenylalanine
22 Recruiting Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
Condition: OMS Grade II Glioma
Intervention: Behavioral: neurocognitive tests
23 Recruiting Supratotal Resection for Gliomas Within Noneloquent Areas
Condition: Glioma
Interventions: Procedure: total resection;   Procedure: supratotal resection
24 Recruiting Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over
Condition: Malignant Glioma
Interventions: Procedure: Surgery;   Radiation: radiotherapy
25 Not yet recruiting Phase 2 Study of IDH305 in Low Grade Gliomas
Condition: Glioma
Intervention: Drug: IDH305
26 Not yet recruiting Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
Condition: Glioma
Intervention: Drug: IDH305
27 Recruiting 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas
Condition: Glioma
Interventions: Drug: 68Ga-NOTA-Aca-BBN;   Device: PET/CT
28 Recruiting Non Invasive Measurements of Intracranial Pressure in Patients With Malignant Glioma
Condition: Glioma
Intervention: Device: noninvasive method of ICP measurements (Elios)
29 Not yet recruiting A Microdose Evaluation Study of ABY-029 in Recurrent Glioma
Condition: Glioma
Intervention: Drug: ABY-029
30 Not yet recruiting MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas
Condition: Glioma
Intervention: Device: MR perfusion imaging
31 Recruiting Hypofractionated Stereotactic Irradiation With Nivolumab in Patients With Recurrent High Grade Gliomas
Condition: Malignant Glioma
Interventions: Radiation: Hypofractionated Stereotactic Irradiation;   Drug: Nivolumab
32 Recruiting Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas
Condition: Glioma
Intervention: Drug: PLB1001
33 Not yet recruiting Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
34 Recruiting Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
Condition: Malignant Glioma
Interventions: Radiation: Hypofractionated Stereotactic Irradiation (HFSRT);   Drug: Pembrolizumab;   Drug: Bevacizumab
35 Recruiting Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
Conditions: Low Grade Glioma;   Malignant Glioma
Intervention:
36 Not yet recruiting Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
37 Recruiting Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia
Condition: Glioma
Interventions: Drug: Dexamfetamine sulphate;   Drug: placebo
38 Recruiting Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Conditions: Diffuse Intrinsic Pontine Glioma;   Brainstem Glioma
Intervention:
39 Recruiting Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
Condition: Malignant Glioma
Intervention: Behavioral: surveys and cognitive tests
40 Recruiting 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Condition: Malignant Glioma
Interventions: Procedure: Diffusion Weighted Imaging;   Drug: Fluorine F 18 Fluorodopa;   Radiation: Intensity-Modulated Radiation Therapy;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography;   Other: Quality-of-Life Assessment;   Drug: Temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.